Using and extending data from a prospective patient cohort established under the framework of the former European Commission’s FP7-supported REQUITE*project*,…
Search Results ""
The Vall d´Hebron Institute of Oncology (VHIO) Seeks a Post-Doctoral Investigator to Join our Chromatin Dynamics in Cancer Group …
Published this week in the August issue of The Lancet Oncology (TLO), a superb Spotlight* debate explores the current performance,…
El 20 d’octubre vinent tindrà lloc la 4a edició de la Pink Run Mir, una cursa solidària que vol reunir…
VHIO and the Catalan Blood & Tissue Bank launch first clinical trial with antiviral T-cell therapy developed entirely in Spain…
La Terrasa runathon organizers are busy making the final arrangements for the second edition of their La Carrera de Las…
The countdown to ESMO Congress 2019 is now on! In anticipation and celebration, VHIO Communications checked in earlier this week…
Further to the rapid emergence of immune-based therapies against cancer, we are seeing increasingly positive results and improved outcomes in…
Referència: 20/2019 Termini de finalització de la presentació: 31/08/2019 Descripció de l’oferta: La Fundació Vall d’Hebron Institut d’Oncologia (VHIO) és…
